Page last updated: 2024-08-18

fluorodeoxyuridylate and cytarabine

fluorodeoxyuridylate has been researched along with cytarabine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abraham, TW; Kalman, TI; McIntee, EJ; Wagner, CR1
Cadman, E; Grant, S1
Au, JL; Danhauser, L; Luccioni, C; Rustum, YM1
Cattaneo-Pangrazzi, RM; Schott, H; Schwendener, RA1
Ballmer-Hofer, K; Klemenz, R; Marty, C; Neri, D; Odermatt, B; Schott, H; Schwendener, RA1

Reviews

1 review(s) available for fluorodeoxyuridylate and cytarabine

ArticleYear
Determinants of response to antimetabolites and their modulation by normal purine and pyrimidine metabolites.
    Cancer treatment reports, 1981, Volume: 65 Suppl 3

    Topics: Animals; Antimetabolites, Antineoplastic; Cytarabine; DNA, Neoplasm; Fluorodeoxyuridylate; Fluorouracil; Humans; Leukemia L1210; Neoplasms; Neoplasms, Experimental; Thymidine; Thymidylate Synthase; Uridine

1981

Other Studies

4 other study(ies) available for fluorodeoxyuridylate and cytarabine

ArticleYear
Synthesis and biological activity of aromatic amino acid phosphoramidates of 5-fluoro-2'-deoxyuridine and 1-beta-arabinofuranosylcytosine: evidence of phosphoramidase activity.
    Journal of medicinal chemistry, 1996, Nov-08, Volume: 39, Issue:23

    Topics: Animals; Cell Division; Cell Line; Cytarabine; Floxuridine; Humans; Magnetic Resonance Spectroscopy; Mice; Organophosphorus Compounds; Phosphoric Monoester Hydrolases; Thymidylate Synthase; Tumor Cells, Cultured

1996
Modulation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in L1210 cells by fluoropyrimidine pretreatment.
    Cancer research, 1982, Volume: 42, Issue:9

    Topics: Animals; Arabinofuranosylcytosine Triphosphate; Cell Line; Cell Survival; Clone Cells; Cytarabine; Deoxyribonucleotides; Deoxyuridine; Drug Interactions; Floxuridine; Fluorodeoxyuridylate; Fluorouracil; Leukemia L1210; Mice; Uridine

1982
The novel heterodinucleoside dimer 5-FdU-NOAC is a potent cytotoxic drug and a p53-independent inducer of apoptosis in the androgen-independent human prostate cancer cell lines PC-3 and DU-145.
    The Prostate, 2000, Sep-15, Volume: 45, Issue:1

    Topics: Androgens; Antimetabolites, Antineoplastic; Apoptosis; Biotransformation; Cell Cycle; Cell Division; Cytarabine; Dimerization; Dose-Response Relationship, Drug; Enzyme Inhibitors; Floxuridine; Fluorodeoxyuridylate; Humans; Hydrolysis; Male; Neoplasms, Hormone-Dependent; Phosphodiesterase I; Phosphoric Diester Hydrolases; Prodrugs; Prostatic Neoplasms; Thymidylate Synthase; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2000
Cytotoxic targeting of F9 teratocarcinoma tumours with anti-ED-B fibronectin scFv antibody modified liposomes.
    British journal of cancer, 2002, Jul-01, Volume: 87, Issue:1

    Topics: Animals; Antibodies, Neoplasm; Antineoplastic Agents; Cytarabine; Female; Fibronectins; Fluorodeoxyuridylate; Immunoglobulin Fragments; Injections, Intravenous; Liposomes; Male; Mice; Mice, Nude; Teratocarcinoma; Testicular Neoplasms; Tissue Distribution; Tumor Cells, Cultured

2002